Citation Formats
Development of multistage recombinant protein vaccine formulations against toxoplasmosis using a new chitosan and porin based adjuvant system
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

S. PARMAKSIZ Et Al. , "Development of multistage recombinant protein vaccine formulations against toxoplasmosis using a new chitosan and porin based adjuvant system," INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.626, 2022

PARMAKSIZ, S. Et Al. 2022. Development of multistage recombinant protein vaccine formulations against toxoplasmosis using a new chitosan and porin based adjuvant system. INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.626 .

PARMAKSIZ, S., Gul, A., Alak, S. E., Karakavuk, M., Can, H., Gul, C., ... Karakavuk, T.(2022). Development of multistage recombinant protein vaccine formulations against toxoplasmosis using a new chitosan and porin based adjuvant system. INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.626.

PARMAKSIZ, SELİN Et Al. "Development of multistage recombinant protein vaccine formulations against toxoplasmosis using a new chitosan and porin based adjuvant system," INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.626, 2022

PARMAKSIZ, SELİN Et Al. "Development of multistage recombinant protein vaccine formulations against toxoplasmosis using a new chitosan and porin based adjuvant system." INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.626, 2022

PARMAKSIZ, S. Et Al. (2022) . "Development of multistage recombinant protein vaccine formulations against toxoplasmosis using a new chitosan and porin based adjuvant system." INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol.626.

@article{article, author={SELİN PARMAKSIZ Et Al. }, title={Development of multistage recombinant protein vaccine formulations against toxoplasmosis using a new chitosan and porin based adjuvant system}, journal={INTERNATIONAL JOURNAL OF PHARMACEUTICS}, year=2022}